Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0015
-0.0002 (-11.76%)
Mar 5, 2026, 2:05 PM EST
Halberd Market Cap
Halberd has a market cap or net worth of $1.23 million as of March 5, 2026. Its market cap has decreased by -37.45% in one year.
Market Cap
1.23M
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 1.23M, a decrease of -52.68%. That is a compound annual growth rate of -4.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.23M | 16.22% |
| Dec 31, 2025 | 1.06M | -58.29% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 1.49M |
| Entia Biosciences | 1.37M |
| Exousia Pro | 1.29M |
| Vaxxinity | 1.27M |
| Evofem Biosciences | 1.15M |
| CERo Therapeutics Holdings | 1.14M |
| International Stem Cell | 1.08M |
| Eastgate Biotech | 1.06M |